Excedrin
- Product NDC
- 85237-1871
- Requested package NDC
- 85237-1871-2
- 11-digit product format
- 852371871
- Labeler code
- 85237
- Product ID
- 85237-1871_46f50269-d18b-0be7-e063-6394a90a6fef
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen, Aspirin, and Caffeine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Select Consumer Group
- Application
- NDA020802
- Marketing category
- NDA
- Marketing start
- 2020-09-30
- Substance
- ACETAMINOPHEN; ASPIRIN; CAFFEINE
- Active strength
- 250; 250; 65 mg/1; mg/1; mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020802-001 | EXCEDRIN (MIGRAINE RELIEF) | ACETAMINOPHEN; ASPIRIN; CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N020802-001 | EXCEDRIN (MIGRAINE RELIEF) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Excedrin Migraine | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Select Consumer Group | 3caa4adf-abe3-67c3-e063-6294a90a87a4 | 2026-07-03 | Warnings | 020802 NDA020802 85237-1871-2 85237-1871 85237187102 |
| Excedrin Migraine | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Navajo Manufacturing Company Inc. | 4efbd21b-92fe-96a7-e063-6294a90ac4ad | 2026-04-08 | Warnings | 020802 NDA020802 |
| EXCEDRIN MIGRAINE | ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE | Haleon US Holdings LLC | 7ed841fb-a61c-4868-b4e5-4f2311a5e79c | 2025-06-25 | Warnings | 020802 NDA020802 |
| Excedrin Migraine Relief | ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE | Haleon US Holdings LLC | dd85f3a7-f4d2-4ea0-a7b6-18ebc0e993d8 | 2025-03-11 | Warnings | 020802 NDA020802 |
| Excedrin Migraine | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Haleon US Holdings LLC | 910d7254-d0f4-4c5c-a26e-7f8acecbe02d | 2025-03-11 | Warnings | 020802 NDA020802 |
| Excedrin Extra Strength Headache | ACETAMINOPHEN, ASPIRIN, CAFFEINE | JC World Bell Wholesale Co., Inc | 29b764c7-3d07-5191-e063-6294a90a9c30 | 2024-12-23 | Warnings | 020802 NDA020802 |
| Excedrin Migraine, TRAVEL BASIX | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Lil' Drug Store Products, Inc. | 40aeb2c5-a37b-446d-9918-8378a75ff327 | 2024-12-13 | Warnings | 020802 NDA020802 |
| Excedrin Migraine | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | A-S Medication Solutions | d012ed1d-b256-48ec-b988-f226c2c5ae9e | 2024-05-29 | Warnings | 020802 NDA020802 |
| EXCEDRIN MIGRAINE | ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE | Haleon US Holdings LLC | 920c8898-e222-4b91-afc5-04d25317ade7 | 2024-03-14 | Warnings | 020802 NDA020802 |
| Excedrin Migraine Geltabs | ACETAMINOPHEN, ASPRIN, CAFFEINE | Haleon US Holdings LLC | cc2f4a6f-2a27-4a60-b5ef-ae0bb0988ff8 | 2024-01-28 | Warnings | 020802 NDA020802 |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | Allegiant Health | 6197eff5-0351-42ef-bb3f-cbc26e6d0d14 | 2018-12-28 | Warnings | 020802 NDA020802 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Excedrin
- Brand name suffix
- Migraine
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 250 mg/1 |
| ASPIRIN | 250 mg/1 |
| CAFFEINE | 65 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
| R16CO5Y76E | Internal UNII lookup |
| 3G6A5W338E | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3caa4adf-abe3-67c3-e063-6294a90a87a4 | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 85237-1871-1 | ExcedrinMigraine | 1 in 1 BLISTER PACK | TABLET, FILM COATED | 1 | 2 | |
| 85237-1871-1 | ExcedrinMigraine | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 2 | |
| 85237-1871-2 | ExcedrinMigraine | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 2 | |
| 85237-1871-2 | ExcedrinMigraine | 2 in 1 BLISTER PACK | TABLET, FILM COATED | 2 | 2 | |
| 85237-1871-3 | ExcedrinMigraine | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 2 | |
| 85237-1871-3 | ExcedrinMigraine | 25 in 1 BOX, UNIT-DOSE | TABLET, FILM COATED | 25 | 2 | |
| 85237-1871-4 | ExcedrinMigraine | 50 in 1 BOX, UNIT-DOSE | TABLET, FILM COATED | 50 | 2 | |
| 85237-1871-4 | ExcedrinMigraine | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 2 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 308297 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet | PSN | 3caa4adf-abe3-67c3-e063-6294a90a87a4 | 2 |
| 209468 | EXCEDRIN 250 MG / 250 MG / 65 MG Oral Tablet | PSN | 3caa4adf-abe3-67c3-e063-6294a90a87a4 | 2 |
| 209468 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet [Excedrin] | SBD | 3caa4adf-abe3-67c3-e063-6294a90a87a4 | 2 |
| 308297 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet | SCD | 3caa4adf-abe3-67c3-e063-6294a90a87a4 | 2 |
| 308297 | APAP 250 MG / ASA 250 MG / caffeine 65 MG Oral Tablet | SY | 3caa4adf-abe3-67c3-e063-6294a90a87a4 | 2 |
| 209468 | APAP 250 MG / ASA 250 MG / Caffeine 65 MG Oral Tablet [Excedrin] | SY | 3caa4adf-abe3-67c3-e063-6294a90a87a4 | 2 |
| 209468 | Excedrin Extra Strength (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral Tablet | SY | 3caa4adf-abe3-67c3-e063-6294a90a87a4 | 2 |
| 209468 | Excedrin Menstrual Complete (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral Tablet | SY | 3caa4adf-abe3-67c3-e063-6294a90a87a4 | 2 |
| 209468 | Excedrin Migraine (APAP 250 MG / ASA 250 MG / caffeine 65 MG) Oral Tablet | SY | 3caa4adf-abe3-67c3-e063-6294a90a87a4 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 85237-1871-2 | 85237187102 | 2 POUCH in 1 BLISTER PACK (85237-1871-2) / 2 TABLET, FILM COATED in 1 POUCH | 2 pouch | 2025-12-24 | No | No | Current |